Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Asian J Endosc Surg. 2021 Apr;14(2):223-231. doi: 10.1111/ases.12857. Epub 2020 Oct 13.
With technique improvements, indications for laparoscopic and endoscopic cooperative surgery (LECS) for gastric subepithelial tumor (SET) are gradually expanding for tumors technically difficult to resect. However, surgical outcomes of LECS, including for esophagogastric junction (EGJ) tumors requiring advanced skills, remain unknown.
We reviewed patients in whom LECS had initially been attempted for gastric SET at the Cancer Institute Hospital in Tokyo from June 2006 to May 2018. Indications for LECS at the EGJ have gradually expanded during the study period to include tumors with esophageal invasion up to 2 cm, or less than half the EJG circumference, preoperatively. Surgical outcomes and risk factors for conversion to other procedures were investigated.
Twenty (9.3%) of the 214 total patients had EGJ tumors. Four patients (20%) with EGJ tumors developed postoperative complications (Clavien-Dindo grade ≥ II). Among 12 patients in whom LECS could be completed for EGJ tumors, only one non-serious complication occurred. Eight patients required conversion to another operation for EGJ tumors (two laparotomy, six proximal gastrectomy). Among conversion cases with EGJ tumors, anastomotic leakage occurred in both patients undergoing laparotomy after LECS, necessitating additional defect closure. There was only one non-serious complication in six proximal gastrectomy patients. On multivariate analysis, EGJ tumor was an independent risk factor for conversion to another operation.
LECS at the EGJ may be a risk factor for conversion operation, and when performing LECS at the EGJ is difficult, conversion to proximal gastrectomy, which can be performed safely, should be considered.
随着技术的进步,腹腔镜和内镜联合手术(LECS)治疗胃黏膜下肿瘤(SET)的适应证逐渐扩大,适用于技术上难以切除的肿瘤。然而,LECS 的手术结果,包括需要高级技能的食管胃结合部(EGJ)肿瘤的手术结果,仍不清楚。
我们回顾了 2006 年 6 月至 2018 年 5 月在东京癌症研究所医院首次尝试用 LECS 治疗胃 SET 的患者。在研究期间,LECS 在 EGJ 的适应证逐渐扩大,包括术前食管侵犯达 2 厘米或 EGJ 周长的一半以下的肿瘤。研究调查了手术结果和转为其他手术的风险因素。
214 例患者中,有 20 例(9.3%)为 EGJ 肿瘤。4 例(20%)EGJ 肿瘤患者发生术后并发症(Clavien-Dindo 分级≥Ⅱ级)。在 12 例能够完成 LECS 治疗 EGJ 肿瘤的患者中,仅发生 1 例非严重并发症。8 例 EGJ 肿瘤患者需要转为另一种手术(2 例剖腹手术,6 例近端胃切除术)。在转为剖腹手术的 EGJ 肿瘤病例中,LECS 后有 2 例发生吻合口漏,需要额外的缺损闭合。在 6 例近端胃切除术患者中,仅发生 1 例非严重并发症。多变量分析显示,EGJ 肿瘤是转为另一种手术的独立危险因素。
EGJ 处的 LECS 可能是转为另一种手术的危险因素,当在 EGJ 处进行 LECS 困难时,应考虑转为近端胃切除术,近端胃切除术可以安全进行。